The ACHIEVE program for type 2 diabetes includes ACHIEVE-1 (NCT05971940, completed), ACHIEVE-2 (NCT06192108, completed), ACHIEVE-3 (NCT06045221, completed), ACHIEVE-4 (NCT05803421), ACHIEVE-5 (NCT06109311, completed), and ACHIEVE-J (NCT06010004, Japan-specific)
Encapsulation of Centella asiatica leaf extract in liposome: study on structural stability, degradation kinetics and fate of bioactive compounds during storage
iPSC-derived homogeneous populations of developing schizophrenia cortical interneurons have compromised mitochondrial function
at Tuna Harbor Dockside Market
Common early signs include reduced appetite, feeling full sooner, fewer cravings, and more stable eating patterns
Glucagon-like peptide-1 receptor signaling modulates beta cell apoptosis